Medical Health & Life Science Research News

Global antibody drug conjugates market scrutinized in new research

Medical Market Research

The Global Antibody Drug Conjugates (ADC) Market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 - 2022. The industry is chiefly driven by a large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates. Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals are the key players profiled in this report.

LEARN ABOUT THIS REPORT
Get research details now! Make an enquiry for a fast response. 

- Advertisement -

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).

More Information: www.researchbymarkets.com/report/g…-us-ica-5271.html Make an Inquiry about this news

Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

Make an Inquiry: www.researchbymarkets.com/inquiry/5271 Make an Inquiry about this news

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period.

LEARN ABOUT THIS REPORT
Get research details now! Make an enquiry for a fast response. 

- Advertisement -
Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years

The report titled, "Global Antibody Drug Conjugates (ADC) Market - Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.

Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Access Full Report: www.researchbymarkets.com/5271 Make an Inquiry about this news

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Antibody Drug Conjugates Market (ADC) Market
• Adcetris Market
• Kadcyla Market
• ADC Pipeline - By Developer, Phase, Indication and Status
• ADC Pipeline - By Cytotoxic Payload, Linker and Target

Regional Markets - N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Antibody Drug Conjugates Market (ADC) Market
• Adcetris Market
• Kadcyla Market
• ADC Pipeline - By Developer, Phase, Indication and Status
• ADC Pipeline - By Cytotoxic Payload, Linker and Target

Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Antibody Drug Conjugates Market (ADC) Market

Other Report Highlights:
• Market Dynamics - Trends, Drivers, Challenges
• Porter's Five Forces Analysis
• SWOT Analysis
• Policy and Regulation
• Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research. 

News From

Research By MarketsResearch By Markets
Category: Market Research Publishers and RetailersCompany about: Research by Markets is an online Market Research Report Repository. Our repository contains reports segmented by Geography and Industry. We cover all major Industry Verticals - Information Technology, Semiconductor, Electronics, Manufacturing, Food & Beverages, Telecommunications, Healthcare, Pharmaceutical, Automotive, BioTechnology, Energy & Power, Banking and many more. We have dedicated Account Managers for Corporate Clients to ensure seamless customer support. Corporates can als ...

For more information:

Make an Inquiry about this report HERE!
  • www.researchbymarkets.com/report/g…-us-ica-5271.html
  • www.researchbymarkets.com/inquiry/5271
  • www.researchbymarkets.com/paynow/5271